Swastham adds Theresa M. Brady to board

Swastham, Inc. has appointed Theresa M. Brady to its Board of Directors as the San Diego-based digital health company builds an AI platform for lifestyle-based care. The move adds more than 30 years of healthcare, compensation, and governance experience to the company’s leadership as it targets chronic disease management and preventive health programs.

Why it matters: - Swastham is trying to scale AI-driven lifestyle health care at a time when chronic disease management and preventive care are under pressure to deliver measurable outcomes. - Brady’s background in healthcare consulting, workforce strategy, compensation, and governance gives Swastham more board-level experience as it builds its digital care platform. - The appointment also puts two women in key leadership roles at the company, with Brady joining Founder and CEO Sucheta Godbole Deshpande.

What happened: - Swastham, Inc. appointed Theresa M. Brady to its Board of Directors on July 10, 2026. - The company is based in San Diego. - Swastham describes itself as an AI-driven digital health company focused on improving access to lifestyle-based care. - Brady will serve as a director alongside Sucheta Godbole Deshpande, the company’s founder and CEO.

The details: - Brady brings more than 30 years of leadership experience. - Her background spans workforce strategy, executive compensation, benefits, financial planning, healthcare compensation analytics and strategic business development. - She spent more than two decades as an owner of Compdata Surveys & Consulting. - At Compdata, Brady served as executive vice president of strategy and development. - Under Brady’s leadership, Compdata became one of the nation’s leading compensation and benefits survey and consulting firms. - Compdata served thousands of organizations across the United States. - Brady has also worked extensively with healthcare associations, hospitals, physician groups and healthcare providers on compensation, benefits, governance and workforce issues. - As a director, Brady will focus on corporate governance, financial stewardship, sustainable growth and long-term stakeholder value. - Swastham is building a native AI platform to scale expert-led chronic disease management and lifestyle health programs. - The company’s platform is designed to help proven health experts turn their protocols into scalable digital care programs. - Swastham’s target areas include metabolic health, musculoskeletal care, sleep, stress and women’s health. - The platform combines expert-led protocols, AI-powered guidance, human oversight and measurable outcome tracking. - Swastham says the platform is meant to make lifestyle-based care more accessible, affordable and scalable.

Between the lines: - The board appointment signals that Swastham is prioritizing governance and operational discipline as it grows. - Brady’s experience in compensation and healthcare consulting suggests Swastham may be positioning itself to work more closely with provider organizations and health systems. - The leadership pairing of Brady and Deshpande suggests the company wants to balance AI innovation with healthcare credibility and oversight. - The company is emphasizing measurable outcomes, which matters because digital health buyers and partners increasingly want proof that care programs improve results.

What's next: - Swastham is expected to keep building out its AI-enabled lifestyle health platform. - Brady will likely support the company’s governance framework and growth strategy as Swastham expands expert-led digital care programs. - The company’s next milestones will likely center on platform development, program scaling and outcome validation.

The bottom line: - Swastham is adding governance experience as it pushes to turn expert-led lifestyle care into a scalable AI-powered digital health business.